BioSpace News Archive

Newron Pharmaceuticals S.p.A. announces that the STARS clinical study (Sarizotan Treatment of Apneas in Rett Syndrome) in patients with Rett syndrome is expected to complete enrollment in H2 2018.

About 1 in 2 colorectal cancers in Canada are diagnosed after they have spread to lymph nodes or other parts of the body, even though most provinces and territories have screening programs designed to catch the disease early or before it starts, according to a new report released today by the Canadian Cancer Society (CCS).

Maxar Technologies announced that Maxar President and CEO Howard Lance will be holding one-on-one and group meetings with investors, as well as participating in a panel discussion on “The Evolution of Commercial Space” at the Melius Research Industrial Tech & Aerospace Forum

CStone Pharmaceuticals announced that two pivotal Phase II studies exploring the efficacy and safety of CS1001 in patients with natural killer cell/T-cell lymphoma (CS1001-201) and classical Hodgkin’s lymphoma (CS1001-202) have been initiated

Elbit Systems Ltd. announced that it’s subsidiary, Beyeonics Surgical Ltd. (“Beyeonics”), concluded a first round of funding raising a $11.5 million investment from leading investment groups including an international corporation.

Zecotek Photonics Inc. is pleased to announce the single largest purchase order of US$5,000,000 for its patented LFS scintillation crystals through a distribution partner in China.

More than 1 in 10 female physicians say they experienced harassment in past three years

ConsumerMedical announced the company has unveiled a new ConsumerMedical Ally Platform™

Proven Visionary Leader and Financial Expert to Help Lead Akonni Through Commercialization

Bill & Melinda Gates Foundation, Li Ka Shing Foundation Lead New Funding Round to Expand Groundbreaking Progress in Restoring Infant Gut Microbiome and to Lay a Global Foundation for Long-Term Nutritional and Immune Health